argenx Balance Sheet
NASDAQ: ARGXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
argenx financial position
At the end of fiscal 2025, argenx reported total assets of $8.68 billion, up 40.0% from a year earlier against total liabilities of $1.36 billion. Shareholders' equity stood at $7.32 billion, or 84.3% of assets. The company held $3.49 billion in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 5.23, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
argenx balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 3.49B | 1.50B | 2.05B | 800.74M | 1.33B | 1.22B | 372.16M | 321.79M |
| Receivables | 1.65B | 904.47M | 496.69M | 275.70M | 38.22M | 6.98M | 31.59M | — |
| Inventory | 473.53M | 407.23M | 310.55M | 228.35M | 109.08M | 25.20M | — | — |
| Total Current Assets | 6.90B | 4.88B | 4.12B | 2.77B | 2.54B | 2.06B | 1.54B | — |
| Property, Plant & Equipment | — | — | 22.68M | 16.23M | 15.84M | 11.58M | 9.18M | — |
| Intangible Assets | 272.10M | 181.44M | 125.23M | 174.90M | 171.68M | 167.34M | 45.12M | — |
| Total Assets | 8.68B | 6.20B | 4.54B | 3.13B | 2.85B | 2.28B | 1.61B | — |
| Accounts Payable | 1.27B | 649.99M | 414.01M | 295.68M | 293.42M | 275.19M | 95.83M | — |
| Total Current Liabilities | 1.32B | 669.92M | 422.99M | 302.28M | 301.24M | 328.49M | 179.70M | — |
| Total Liabilities | 1.36B | 704.24M | 444.95M | 320.56M | 316.05M | 605.36M | 429.81M | — |
| Shareholders' Equity | 7.32B | 5.50B | 4.10B | 2.81B | 2.53B | 1.67B | 1.18B | 616.46M |
| Retained Earnings | -279.77M | -1.57B | -2.40B | -2.11B | -1.40B | -991.93M | -383.48M | -169.60M |
| Net Cash (Debt) | 3.49B | 1.50B | 2.05B | 800.74M | 1.33B | 1.22B | 372.16M | 321.79M |
| Shares Outstanding | 61.88M | 60.76M | 59.19M | 55.40M | 51.67M | 47.57M | 42.76M | 35.98M |
This table shows 8 annual periods of argenx's balance sheet, from FY 2025 back to FY 2018, across 14 line items including cash & equivalents, receivables, inventory. Values in USD; B = billions, M = millions. Fiscal periods follow ARGX's reporting calendar. What is a balance sheet?